NDC 55154-8713 Myrbetriq
Mirabegron Tablet, Film Coated, Extended Release Oral - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 55154 - Cardinal Health 107, Llc
- 55154-8713 - Myrbetriq
Product Characteristics
YELLOW (C48330)
ASTELLAS;LOGO;355
Product Packages
NDC Code 55154-8713-8
Package Description: 1080 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product Details
What is NDC 55154-8713?
What are the uses for Myrbetriq?
What are Myrbetriq Active Ingredients?
Which are Myrbetriq UNII Codes?
The UNII codes for the active ingredients in this product are:
- MIRABEGRON (UNII: MVR3JL3B2V)
- MIRABEGRON (UNII: MVR3JL3B2V) (Active Moiety)
What is the NDC to RxNorm Crosswalk for Myrbetriq?
- RxCUI: 1300791 - mirabegron 25 MG 24HR Extended Release Oral Tablet
- RxCUI: 1300791 - 24 HR mirabegron 25 MG Extended Release Oral Tablet
- RxCUI: 1300791 - mirabegron 25 MG 24 HR Release Tablet
- RxCUI: 1300797 - Myrbetriq 25 MG 24HR Extended Release Oral Tablet
- RxCUI: 1300797 - 24 HR mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq]
Which are the Pharmacologic Classes for Myrbetriq?
* Please review the disclaimer below.
Patient Education
Mirabegron
Mirabegron is used alone or in combination with solifenacin (Vesicare) to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) in adults. It is also used to treat neurogenic detrusor overactivity (a bladder control condition caused by brain, spinal cord or nerve problem) in children 3 years of age and older. Mirabegron is in a class of medications called beta-3 adrenergic agonists. It works by relaxing the bladder muscles to prevent urgent, frequent, or uncontrolled urination.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".